Related Experiment Video

Updated: Aug 24, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Anticancer agents: tumor cell growth inhibitory activity and binary QSAR analysis

Steven S Ren1, Eric J Lien

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, CA 90089-9121, USA. sren@maxim.com

Current Pharmaceutical Design
|May 12, 2004
PubMed

Insights

Molecular weight is a key factor in anticancer drug activity. A new quantitative structure-activity relationship (QSAR) model can predict drug effectiveness and aid in screening new compounds.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Computational Biology

Background:

  • The National Cancer Institute (NCI) anticancer drug screening program investigates numerous compounds.
  • Understanding physicochemical properties is crucial for predicting anticancer activity.

Purpose of the Study:

  • To analyze the influence of physicochemical parameters on tumor cell growth inhibition.
  • To develop a predictive quantitative structure-activity relationship (QSAR) model for anticancer agents.

Main Methods:

  • Analysis of tumor cell growth inhibitory activities (log 1/GI(50)) for 166 anticancer agents.
  • Correlation analysis of activities across different tumor cell subpanels.
  • Development of a binary QSAR model based on activity (active/inactive) and molecular weight (log MW).

Main Results:

  • Increased molecular weight (log MW) positively correlates with enhanced tumor cell growth inhibitory activity.
  • Tumor cell growth inhibitory activities are highly inter-correlated across different cell types.
  • A simple binary QSAR model was successfully derived from the dataset.

Conclusions:

  • Molecular weight is a significant physicochemical parameter influencing anticancer drug efficacy.
  • The developed QSAR model can predict the activity of new anticancer compounds.
  • This model can assist in identifying promising drug candidates from large libraries for high-throughput screening.

More Related Videos

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds10:16

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Published on: June 6, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...